NASDAQ:AMRN
Amarin Corporation PLC Stock News
$0.87
+0.0148 (+1.72%)
At Close: Apr 26, 2024
Hedge Funds Aren’t Done Buying Amarin Corporation plc (AMRN)
05:38pm, Monday, 01'st Jun 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Amarin Plans to Increase VASCEPA® (icosapent ethyl) Promotion and Education
11:00am, Monday, 01'st Jun 2020
DUBLIN, Ireland and BRIDGEWATER, N.J., June 01, 2020 -- Amarin Corporation plc (NASDAQ:AMRN), today announced that it intends to increase the level and breadth of its promotion.
Amarin Continues Its Fight Against Generic Vascepa (NASDAQ:AMRN)
02:05am, Monday, 01'st Jun 2020
In late March, the Nevada district court judge ruled in Amarin's favor that certain proposed generic products would induce infringement of the company's asserte
FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID-19 Patients with Right Heart Failure
12:00am, Monday, 01'st Jun 2020
The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for Impella RP to include patients suffering from
Hikma Pharmaceuticals : USA launches Dicyclomine Hydrochloride Oral Solution USP in US | MarketScreener
12:12pm, Friday, 29'th May 2020Will Courts Reverse Earlier Ruling on Amarin Patents? Analyst Weights In
09:02pm, Thursday, 28'th May 2020
It has been a rough couple of months for pharma company Amarin Corporation (AMRN). At the end of 2019, the cardiovascular health-focused name was flying high after the FDA expanded the labeling for it
INSIDE STORY: How Kogi is turning a blind eye to patients with COVID-19 symptoms - TheCable
09:11am, Thursday, 28'th May 2020
It was scorching hot on Saturday afternoon in Lokoja, Kogi, when Godwin (not real name) managed to drag himself to one of the hospitals in th
Biocon gets DCGI nod for device to treat critical COVID-19 patients
11:22am, Wednesday, 27'th May 2020
The company has been granted licence for emergency use of CytoSorb, an extracorporeal blood purification device CytoSorb to reduce pro-inflammatory cytokines levels, to treat COVID-19 patients who are
